Intrinsiqq
Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation

EW

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$60.62B
EPS$1.77
P/E59.56
P/FCF42.57
EV/EBITDA35.16
FCF Yield2.3%
Div. Yield–
Net Debt/FCF-2.8x
Edwards Lifesciences Corporation intrinsic value
52-Week Range
$75.87$107.15

Profitability & Returns

Revenue (TTM)

$6.67B

▲ +11.5% YoY

Net Income (TTM)

$1.02B

▼ -74.3% YoY

Op. Margin

21.59%

▼ -4.5pp YoY

ROIC

8.86%

▼ -4.0pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$1.42B

▲ +360.5% YoY

Op. Cash Flow (TTM)

$1.72B

▲ +194.2% YoY

Net Debt

-$3.94B

Net Cash Position

Cash & Equiv.

$4.64B

5Y CAGR: +6.7%

5Y CAGR: +15.6%

Continue Research

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with EW

CompareIntrinsic value
STESTERIS plc
$257.41-1.72%70
ZBHZimmer Biomet Holdings, Inc.
$102.09+0.67%66
ALGNAlign Technology, Inc.
$163.46-1.52%70
ENOVEnovis Corporation
$27.22-2.51%42
MSAMsa Safety Inc.
$172.84+1.38%75
ISRGIntuitive Surgical Inc.
$430.53-1.65%83
BBLGBone Biologics Corporation
$0.31+5.10%21
AVNSAvanos Medical Inc.
No recent price12

Held by ETFs

EW is in 288 US ETFs. The largest of them, with EW's weight in each:

Edwards Lifesciences (EW) in four numbers

Fair value (earnings)
$48.90
Price $105.43 is 116% above it.
Intrinsic Value
Quality score
60/100
Best check: revenue growth, 10.6%. Weakest: margin trend, -12.0pp.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
59.56
Price to free cash flow 42.57.
Financials

Questions about Edwards Lifesciences

Is Edwards Lifesciences (EW) overvalued?

At $105.43, Edwards Lifesciences' price is 116% above the $48.90 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 59.56 times earnings and 42.57 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Edwards Lifesciences' fair value?

Intrinsiqq's calculator puts Edwards Lifesciences' fair value at $48.90 a share. It grows earnings per share 8.2% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $36.67. Every input can be changed on the Intrinsic Value tab.

Is Edwards Lifesciences a high-quality business?

Edwards Lifesciences scores 60 out of 100 on Intrinsiqq's quality score, which makes it a solid business on these measures. The score blends 8 checks computed from SEC filings. Its best check is revenue growth at 10.6%, and its weakest is margin trend at -12.0pp. The Quality tab shows every check against its target.

Does Edwards Lifesciences (EW) pay a dividend?

No. Edwards Lifesciences (EW) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Over the last twelve months it returned cash through share buybacks instead, equal to a 1.2% buyback yield. The Dividends tab shows its cash returns.

Source: 10-Q filed 31 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 17 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in EW's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing EW

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.